Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma (Skin)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03015883
What this trial is testing

Alpha Radiation Emitters Device for the Treatment of Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma
Alpha Tau Medical LTD. 28
Early research (Phase 1)Temporarily pausedNCT04714983
What this trial is testing

DNX-2440 for Resectable Colorectal Liver Metastasis

Who this might be right for
Liver MetastasesLiver Metastasis Colon CancerColorectal Cancer+8 more
DNAtrix, Inc. 30
Not applicableStudy completedNCT00132704
What this trial is testing

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

Who this might be right for
Ovarian NeoplasmsColorectal NeoplasmsMelanoma+2 more
Memorial Sloan Kettering Cancer Center 149
Early research (Phase 1)Study completedNCT03652077
What this trial is testing

A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies

Who this might be right for
Cervical CancerGastric CancerStomach Cancer+18 more
Incyte Corporation 40
Early research (Phase 1)Active Not RecruitingNCT03983954
What this trial is testing

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

Who this might be right for
ER+ Breast CancerOvarian CancerCervical Squamous Cell Carcinoma+17 more
NeoTX Therapeutics Ltd. 120
Early research (Phase 1)UnknownNCT03775525
What this trial is testing

Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer

Who this might be right for
Advanced CancerGastric CancerBreast Cancer+14 more
Genzada Pharmaceuticals USA, Inc. 127
Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Early research (Phase 1)Ended earlyNCT06546553
What this trial is testing

Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.

Who this might be right for
NeoplasmsNon-small-cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+3 more
Pfizer 10
Not applicableStudy completedNCT05935995
What this trial is testing

Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination

Who this might be right for
Squamous Cell Carcinoma of Head and NeckBasal Cell Carcinoma of Skin
Institut de Cancérologie de Lorraine 42
Early research (Phase 1)UnknownNCT05311618
What this trial is testing

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 71
Early research (Phase 1)Study completedNCT02318771
What this trial is testing

Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Renal Cell CancerRecurrent Head and Neck Carcinoma+6 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 41
Early research (Phase 1)Ended earlyNCT06870487
What this trial is testing

Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

Who this might be right for
Peripheral T Cell LymphomaDiffuse Large B-cell LymphomaClassical Hodgkin Lymphoma+3 more
Pfizer 6
Testing effectiveness (Phase 2)UnknownNCT05490485
What this trial is testing

Camrelizumab Combined With Cisplatin in the Treatment of Advanced Cutaneous Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Skin
Henan Cancer Hospital 20
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Not applicableLooking for participantsNCT07241585
What this trial is testing

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

Who this might be right for
Nonmelanoma Skin CancerBasal Cell CarcinomaSquamous Cell Carcinoma
Case Comprehensive Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT04609566
What this trial is testing

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck
Seagen, a wholly owned subsidiary of Pfizer 161
Testing effectiveness (Phase 2)Ended earlyNCT02521870
What this trial is testing

A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Metastatic MelanomaHead Neck Cancer
Dynavax Technologies Corporation 241
Not applicableStudy completedNCT00476905
What this trial is testing

Spectral Diagnosis of Cutaneous Malignancy

Who this might be right for
Skin Cancer
M.D. Anderson Cancer Center 350
Early research (Phase 1)Looking for participantsNCT05005403
What this trial is testing

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Who this might be right for
Non-Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaMicro Satellite Stable Colorectal Cancer+4 more
AbbVie
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07455331
What this trial is testing

Flash Radiotherapy for Skin Cancer

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)Basal Cell Carcinoma (BCC)
Jules Bordet Institute 60
Next Page
694